MEDP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MEDP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-01), Medpace Holdings's share price is $388.57. Medpace Holdings's Owner Earnings per Share (TTM) ended in Mar. 2024 was $13.96. It's Price-to-Owner-Earnings for today is 27.83.
The historical rank and industry rank for Medpace Holdings's Price-to-Owner-Earnings or its related term are showing as below:
During the past 11 years, the highest Price-to-Owner-Earnings of Medpace Holdings was 48.61. The lowest was 13.25. And the median was 24.26.
As of today (2024-05-01), Medpace Holdings's share price is $388.57. Medpace Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $9.81. Therefore, Medpace Holdings's PE Ratio for today is 39.61.
As of today (2024-05-01), Medpace Holdings's share price is $388.57. Medpace Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was $9.81. Therefore, Medpace Holdings's PE Ratio without NRI for today is 39.61.
During the past 11 years, Medpace Holdings's highest PE Ratio without NRI was 297.30. The lowest was 22.92. And the median was 33.22.
The historical data trend for Medpace Holdings's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Owner-Earnings | Get a 7-Day Free Trial | 20.12 | 24.12 | 48.61 | 20.64 | 26.26 |
Medpace Holdings Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial | 16.47 | 21.50 | 21.54 | 26.26 | 28.94 |
For the Diagnostics & Research subindustry, Medpace Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Medpace Holdings's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Medpace Holdings's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 388.57 | / | 13.96 | |
= | 27.83 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings (NAS:MEDP) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Medpace Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Susan E Burwig | officer: Exec. VP, Operations | C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
August J. Troendle | director, 10 percent owner, officer: CEO | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Medpace Investors, Llc | 10 percent owner | 4620 WESLEY AVENUE, CINCINNATI OH 45212 |
Robert O. Kraft | director | ONE CVS DRIVE, WOONSOCKET RI 02895 |
Kevin M. Brady | officer: CFO & Treasurer | MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Stephen P Ewald | officer: General Counsel & Corp. Secy. | C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227 |
Femida H. Gwadry-sridhar | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Ashley M. Keating | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Davenport Fred B Jr | director | |
Brian T Carley | director | C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Mccarthy Cornelius P. Iii | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Jesse J Geiger | officer: CFO & COO, Lab Operations | C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Tom C King | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Medpace Limited Partnership | 10 percent owner | EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP |
Cinven Capital Management (v) General Partner Ltd | 10 percent owner | EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 09-08-2021
By GuruFocus Research GuruFocus Editor • 12-04-2021
By GuruFocus Research • 06-09-2023
By GuruFocus Research GuruFocus Editor • 09-01-2021
By GuruFocus Research GuruFocus Editor • 11-25-2021
By Business Wire Business Wire • 03-17-2022
By GuruFocus Research GuruFocus Editor • 12-18-2021
By GuruFocus Research GuruFocus Editor • 12-10-2021
By GuruFocus Research GuruFocus Editor • 11-30-2021
By GuruFocus Research GuruFocus Editor • 12-02-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.